INTRODUCTION
Acute myeloid leukemias (AMLs) are characterized by an abnormal accumulation of hematopoietic progenitors in the bone marrow (BM), leading to the hematopoietic insufficiency responsible for the clinical picture of AMLs. The AML-phenotype seems to be maintained by an accelerated proliferation of blast cells in the BM considered to be due to a combination of two components: i) the block of differentiation hindering progenitors to reach the post-proliferative stage and to subsequently undergo apoptosis; ii) the increase of self-renewal of the leukemic progenitors.
AMLs are frequently associated with specific chromosomal translocations, such as t(15;17), t(11;17) and t (8;21) resulting in the generation of chimeric genes 1, 2 . These genes encode chimeric transcription factors, such as PML/RAR , PLZF/RAR and AML-1/ETO which deregulate transcription of target genes of their physiological counterparts [1] [2] [3] . Accordingly, the expression of PML/RAR as well as of PLZF/RAR in animal models leads to the development of a leukemic phenotype [4] [5] [6] . In contrast, the expression of AML1/ETO alone induces alterations of hematopoiesis in vivo but does not lead to the development of leukemia 7, 8 .
In different cell line models these AATP induce a differentiation block by interfering with chromatinremodeling through aberrant recruitment of histone-deacetylases (HDACs) to promoters of genes relevant for differentiation 9 . Increased HDAC-activity hinders the access of the transcription machinery to these chromatin segments [10] [11] [12] . Furthermore AATPs interact physically with transcription factors indispensable for differentiation, such as the vitamin D 3 (VitD 3 )-receptor (VDR) in VitD 3 -induced monocytic differentiation. As a consequence VDR is dislocalized and becomes unable to activate its target genes 13 .
The contribution of impaired apoptosis to the pathogenesis of AML still remains to be defined. Wild-type PML plays a crucial role in a variety of apoptosis-signaling pathways and in the regulation of p53-activity [14] [15] [16] [17] [18] . The PML/RAR fusion protein encoded by the t(15;17) translocation leads to the disruption of the functional PML structures, the so called PML-nuclear bodies, suggesting that at least this AATP interferes with apoptosis 14, 15 .
The ability of leukemic progenitors for increased self-renewal may result from the combination of the differentiation block and the reduced apoptosis rate. In addition there could be factors inducing
For personal use only. on . by guest www.bloodjournal.org From 4 increased self-renewal independently of the differentiation block and impaired apoptosis. Recently, it has been shown that the activation of the Wnt-signaling pathway is able to promote self-renewal in hematopoietic stem cells (HSCs). Wnt3a activates -catenin by stabilizing it in the cytosol and induces known Wnt-targets such as MYC, cyclin D1 and MSX1 19 . Furthermore, over-expression of -cateninthe main down-stream mediator of Wnt-signaling -elevates self-renewal of HSCs through the canonical Wnt-pathway mediated by the LEF-1/Tcf complex 20 . Also the activation of Wnt-signaling in human
HSCs leads to an increase of self-renewal. In fact, the exposure of human HSCs to Wnt5a further augments the number of NOD-SCID repopulating cells 21 .
We have recently shown that PML/RAR , PLZF/RAR as well as AML-1/ETO activate Wntsignaling by increasing -catenin expression 22 .
-catenin is closely related to -catenin, and is able to transform cells, whereas -catenin exhibits a transforming capacity only when it is constitutively stabilized by mutation 23 .
In order to delineate the contribution of -catenin in leukemogenesis, we studied the impact of -catenin in determining the phenotype caused by expression of AATPs in HSCs.
MATERIALS AND METHODS

Plasmids
The retroviral vectors used in this study were all derived from the bi-cistronic PINCO vector. PINCO-PML/RAR was kindly provided by PG. Pelicci, IEO, Milan, Italy, and PINCO--catenin by C. Müller-Tidow, Münster-University, Germany. PINCO-PLZF/RAR was created using the unique EcoRI site of PINCO. The pGL3--catenin construct was kindly provided by G. Brabant, MTH, Hannover, Germany.
The pGL3basic and pRL-CMV vectors were purchased from Promega (Mannheim, Germany). The siRNA expression vector vPGKpuroU3U6 was constructed by inserting the human U6 promoter from -265 bp to -1 bp into the U3 region of vPGKpuro vector using BbsI and HpaI restriction sites. The vPGKpuro was obtained by replacing the SV40 promoter driving the puromycin resistance by the mouse 
Cell lines
Mock-transfected U937 MT, PML/RAR -expressing U937 P/R9 24 , PLZF/RAR -expressing U937 B412 25 and AML-1/ETO expressing U937 A/E cells 13 were maintained in RPMI1640 (Invitrogen, Karlsruhe, Germany) plus 10% fetal calf serum (FCS)(Invitrogen, Karlsruhe, Germany). 32D cells were maintained in RPMI1640 plus 10% FCS supplemented with 10ng/mL of rm-IL3 (Cell Concepts, Umkirch, Germany).
The ecotropic Phoenix packaging cells were cultured in Dulbecco's modified Eagle medium (DMEM)(Invitrogen, Karlsruhe, Germany) plus 10% FCS.
Western blotting
Western blotting was performed according to widely established protocols. Anti-RAR (C20) and anti--catenin (H80) antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA), the anti--tubulin antibody (DMB1B) from Calbiochem, (Darmstadt, Germany) and secondary horseradishperoxidase-conjugated antibodies from Dianova (Hamburg, Germany). For "stripping", the blots were treated with "Restore Western Blot Stripping Buffer" according to the manufacturer's instructions (Pierce, Rockford, USA).
Transactivation assay
12.5µg pRL-CMV plasmid was co-transfected with 40 µg PGL3--catenin or pGL3basic into U937 MT, U937 P/R9, U937 B412 and U937 A/E cells by electroporation as described previoulsy 25 . 16 hours later transgene expression was induced by the exposure of the cells to 100 µM Zn 2 SO 4 (Sigma, Steinheim, Germany). 24 hours after Zn 2+ -treatment luciferase activity was determined using the "Dual-luciferase
Reporter Assay System" (Promega, Mannheim, Germany) according to the manufacturer's instructions.
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Isolation of Sca1/lin-HSCs
Sca1+/lin-HSCs were isolated from female C57BL/6N mice from 6 to 12 weeks of age (Charles, River, Sulzfeld, Germany) killed by CO 2 asphyxiation. BM was harvested from femura and tibiae by flushing the bones with syringe and 26-gauge needle. Sca1+ cells were purified by immunomagnetic beads using the "MACS" cell separation columns according to the manufacturer's instruction (Myltenyi, BergischGladbach, Germany). Sca1+ cells were "lineage depleted" by labeling the cells with biotin-conjugated lineage panel antibodies B220, CD3 , Gr-1, Mac-1, TER-119 (Pharmingen, San Diego, California).
Labeled cells were removed using streptavidin loaded "MACS" cell separation columns (Myltenyi, Bergisch-Gladbach, Germany). Purified cells were pre-stimulated prior to further use for 2 days in medium, containing mIL-3 (20 ng/mL), mIL-6 (20 ng/mL) and mSCF (100 ng/mL)(Cell Concepts, Umkirch, Germany).
Retroviral infection
Phoenix cells were transfected with retroviral vectors as described before 13 . Retroviral supernatant was collected at day 2 and 3 after transfection. Target cells were plated onto retronectin-coated (Takara-Shuzo, Shiga, Japan) non-tissue culture-treated 24-well-plates and exposed to the retroviral supernatant for 3 hours at 37°C in the presence of 4 µg/ml polybrene (Sigma, Steinheim, Germany). Cells were centrifuged at 2.200 rpm. for 45 minutes. Infection was repeated 4 times and infection efficiency had to be at least 70% as assessed by the detection of GFP positive cells by "fluorescence enhanced cell sorting" (FACS) and differences of infection efficiency between the samples did not exceed 10%.
Colony assays, replating efficiency, differentiation
At day 5 after infection Sca1+/lin-cells were plated at 5000 cells/mL into methyl-cellulose supplemented with mIL-3 (20 ng/mL), mIL-6 (20 ng/mL) and mSCF (100 ng/mL)(StemCell Technologies, Vancouver, Canada). On day 10 after plating the colony number was counted. After washing out from methylcellulose cells were cytocentrifuged for morphological analysis and stained for the determination of surface marker expression by FACS. 5000 cells/plate were plated again in methyl-cellulose determining replating efficiency by serial plating. Differentiation was assessed by May-Grünwald-Giemsa staining of the cytospins, by expression of c-kit, Sca -1, Gr-1 and Mac1 (Pharmingen, San Diego, CA) by FACS.any).
Cell cycle analysis
Sca1+/lin-cells were collected from cultures 6 days and 32D cells 36h after infection, washed in PBS and fixed with 70% ethanol at -20°C. The cells were resuspended in PBS containing Propidium Iodide (PI)(50ug/ml) and RNAse (5ug/ml) (Sigma, Steinheim, Germany) and incubated at 37°C for 30 
Transduction/Transplantation model of leukemia
Female C57BL mice from 6 to 12 weeks of age (Charles River, Sulzfeld, Germany) were used as transplant recipients and donors. Sca1+/lin-were isolated as described above. Recipients were sublethally irradiated with 8.5 Gy. 5x10 4 transduced Sca1+/lin-HSCs were inoculated into anesthetized mice by retro-orbital injection. For the engraftment control one mice of each group was sacrificed and analyzed.
The other mice were sacrificed at the first appearance of signs of morbidity, loss of weight (>10%), neurological abnormalities, failure to thrive or diarrhea. Isolation of BM cells was performed as described above. Spleen cells were isolated by passing the tissue through a 40µM Nylon cell strainer (BecktonDickinson, Le Pont de Claix, France). Whole BM and spleen cells were then cytospined on glass slides and stained with May-Grünwald-Giemsa. For surface marker analysis and protein lysate preparation the MNC were enriched on a Ficoll density gradient.
RESULTS
X-RAR block myeloid differentiation of Sca1+/lin-HSCs
To investigate whether X-RAR are able to inhibit differentiation of HSCs we expressed PML/RAR as well as PLZF/RAR in Sca1+/lin-HSCs by retroviral infection. The cells were seeded in semi-solid medium and exposed to G/GM-CSF for 10 days to induce granulocytic/monocytic differentiation. Mockinfected cells served as negative controls. Differentiation was assessed by morphology and by expression of differentiation-associated surface markers (Gr-1, Mac-1, Sca1 and c-kit). As depicted in Figure 1A Taken together these data indicate that the expression of X-RAR not only blocks G/GM-CSF-induced differentiation of Sca1/lin-stem cells, but moreover retains the cells at an early progenitor stage.
X-RAR increase self-renewal of HSCs
To investigate whether the differentiation block related to the expression of X-RAR is responsible for the increased self-renewal of the leukemic stem cells we evaluated the effect of X-RAR on the replating efficiency of Sca1+/lin-HSCs. Therefore, PML/RAR -and PLZF/RAR -transduced Sca1+/lin-cells In summary, these data demonstrate that the expression of X-RAR increases the potential for selfrenewal of HSCs and leads to an acceleration of cell cycle progression in early progenitors.
AATPs activate the -catenin promoter
We have recently shown that expression of X-RAR or AML-1/ETO induces expression of -catenin, a key mediator of the Wnt-signaling pathway. Activation of Wnt-signaling increases the self-renewal of HSCs. To clarify the role of the Wnt-signaling mediated by -catenin in the X-RAR -related leukemogenesis we investigated whether the X-RAR can induce expression of -catenin in vivo.
Therefore, X-RAR -transduced Sca1+/lin-HSCs were transplanted into sublethally irradiated mice. As catenin-promoter by the AATPs. Exposure to t-RA reduced the transactivation of the -catenin promoter by PML/RAR in U937 cells, however, the reduction did not reach the levels of control cells lacking the translocation products ( Figure 3C ). In contrast, t-RA had no effect on the transactivation of the -catenin promoter by PLZF/RAR or AML-1/ETO, neither did it influence the basic activation of the -catenin promoter in the MT control cells.
Taken together these data indicate that the AATPs up-regulate -catenin expression by directly transactivating the -catenin promoter, an effect which is at least partially reversible by t-RA in the case of the APL t(15;17)-associated translocation product PML/RAR .
-catenin accelerates cell cycle progression of HSCs
To disclose the role of the -catenin for the phenotype induced by the AATPs we compared the In summary these data show that one of the main effects of -catenin in HSCs is an acceleration of cell cycle progression.
For
Over-expression of -catenin selects a subset of early HSCs unable to differentiate in presence of G/GM-CSF
The capacity of the activated Wnt-signaling pathway to increase self-renewal of HSCs and the fact thatcatenin accelerates cell cycle progression comparable to X-RAR , prompted us to investigate the influence of -catenin over-expression on the replating efficiency ofHSCs in comparison to that of the AATPs. Thus -catenin transduced Sca1+/lin-cells were compared with cells transduced with PML/RAR , PLZF/RAR and AML-1/ETO and seeded in methyl-cellulose as described above. The CFUs were counted after 10 days in each plating round ( Figure 5A ). All groups showed a similar reduction in CFUs in the second plating. In the third plating only few differentiated CFUs were seen in the mock-infected controls, and these were not further replatable. In contrast, the AATP-positive cells yielded a high number of CFUs, whereas the number of -catenin-positive CFUs increased only slightly ( Figure 5A ). The cells of the fourth plating were further analyzed. As shown in Figure 5B , the expression of -catenin led to the formation of homogenous, very small and compact colonies similar to CFU-GEMM, but without peripheral migrating cells very similar to "blast-colonies", indicating that these colonies were formed by a completely immature cell population. In contrast, expression of PML/RAR as well as PLZF/RAR gave origin to a mixture of CFU-GEMM and CFU-GM, but this was observed in addition to colonies identical to those seen in the -catenin-expressing cells (indicated by arrows in Figure   5B ). The immature character of -catenin over-expressing HSCs is confirmed by the nearly exclusive expression of c-kit and Sca1 in comparison to PML/RAR -and PLZF/RAR -expressing colonies. In fact, neither GR-1 nor Mac1 expression was detected in these cells ( Figure 5C ). In contrast to thecatenin-expressing CFUs -represented by one population expressing high levels of c-Kit and Sca1 -two subpopulations can be distinguished in the PML/RAR -as well as PLZF/RAR -expressing CFUs, one with high expression and one with low expression of Sca1 which is in accordance with a certain degree of myeloid differentiation. The morphology of -catenin-expressing cells did not exhibit any sign of myeloid differentiation, which is in contrast to the PML/RAR -as well as the PLZF/RAR -expressing cells where signs of early myeloid differentiation were seen ( Figure 5D ). Moreover, exposure of these cells to In summary, these data show that the over-expression of -catenin in HSCs leads to the selection of a subset of early stem cells which may contribute to leukemogenesis.
-catenin is essential for the increased colony forming capacity of HSCs overexpressing AATPs
To corroborate our hypothesis that -catenin is crucial for the increased replating efficiency of AATPpositive CFU, up-regulation of endogenous -catenin by AATPs in the HSCs was inhibited by RNA interference.
Different siRNA directed against -catenin were expressed from the human U6 promoter in a retroviral vector and expression of -catenin was assessed by Western blotting. Figure 6A shows the effects of two siRNAs on -catenin expression. As siRNA-25 proved to be more efficient, it was used for all further experiments.
First we investigated the effect of hindered -catenin expression on cell cycle progression induced by X-RAR by transducing X-RAR expressing Sca1+/lin-cells with siRNA-25. As shown in Figure 6B the presence of siRNA-25 did not significantly affect the cell cycle progression of Sca1+/lin-cells expressing the AATPs. In a comparable experimental setting we studied the effect of siRNA-25 on the replating efficiency of Sca1+/lin-stem expressing the AATPs. In contrast to the control siRNA directed against bacterial -galactosidase (siRNA-LacZ), which did not have any influence on colony formation, the presence of siRNA-25 almost completely abolished the colony forming capacity of the HSCs expressing the AATPs already in the third plating ( Figure 6C ). The presence of the siRNA-25 not only reduced the number but also the size of the colonies ( Figure 6C ). The effect of siRNA-25 was not limited to the cells expressing the AATPs, but also diminished the colony size of mock-infected control cells ( Figure 6C ).
We continued the replatings for another 4 rounds and showed that the AATPs-positive cells were unable to rescue their CFU forming capacity in presence of siRNA-25 ( Figure 6C and data not shown) . The analysis of surface marker expression at the second plating yielded no significant differences between Taken together these data indicate that -catenin may be important for the self-renewal of HSCs, but is dispensable for the differentiation block caused by the expression of AATPs.
-catenin overexpression in HSCs induces myeloid leukemia
To clarify the role of -catenin in the X-RAR -related leukemogenesis and to explore the possibility to expand HSCs for therapeutic issues through an over-expression of -catenin or a pharmacological induction of Wnt-signaling, we inoculated five mice with Sca1+/lin-cells transduced with -catenin. One animal was sacrificed to confirm engraftment on day 10 after transplantation (see above), the other four were observed for 12 months for the development of leukemia. In contrast to the above described PML/RAR -and PLZF/RAR -positive mice, which did not develop leukemia within 12 months (data not shown), one of the -catenin-positive mice exhibited the clinical picture of acute leukemia after 9 months. MNCs isolated from both the spleen and the BM expressed high levels of -catenin as determined by Western blotting ( Figure 7A ). There was a high rate of immature myeloid blasts in the BM as well as in the spleen ( Figure 7B ). These blasts expressed high levels of GR-1 and Mac-1 in the BM, but low levels of these marker in the spleen ( Figure 7C ), indicating that the population residing in the spleen is less differentiated than the one in the BM where nearly normal megakaryopoiesis took place ( Figure 7B ).
Peripheral WBC were 33.75/nL, whereas RBC, hemoglobin levels and thrombocyte counts were within the normal range (data not shown). After 12 months another animal developed disease symptoms and was sacrificed. In this mouse GFP was still detectable, which is driven in the PINCO vector by a CMV promoter, often silenced in vivo 27 . In the spleen only the GFP-positive cells showed an expression pattern of surface markers consistent with the presence of myeloid leukemia, whereas the GFP-negative population exhibited a nearly normal pattern of surface markers. In the BM both the GFP-positive and the GFP-negative population were constituted by leukemia cells ( Figure 7C ). The morphological analysis of MNC isolated from the spleen and the BM gave a picture of a myeloid leukemia with signs of differentiation ( Figure 7D ) 28 .
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The other two mice were sacrificed for analysis at the end of month 12 after transplantation. Both mice showed clearly impaired hematopoiesis in the BM as well as in the spleen with a clear increase of myeloid markers (data not shown).
Taken together these data indicate that the inoculation of sublethally irradiated recipient mice with HSCs over-expressing -catenin can establish acute myeloid leukemia.
DISCUSSION
The aim of this study was to clarify whether the increased self-renewal of leukemic blasts is directly related to the differentiation block or if the differentiation block and self-renewal are independent features contributing both to the leukemic phenotype. Here we propose a mechanism by which AML-M3-associated X-RAR as well as AML-M2-associated AML-1/ETO increase self-renewal of HSCs. We disclosed a crucial role of -catenin, a member of the Wnt-signaling cascade, for the determination of the phenotype related to the expression of AATPs.
The first indication that the increase of the self-renewal may be at least in part independent of the differentiation block is given by the different phenotypes induced by AML-M3-related X-RAR and AML-M2-related AML-1/ETO. Here we show that X-RAR induce a phenotype in HSCs which comprises the differentiation block, increased self-renewal and accelerated cell cycle progression. X-RAR block differentiation at an early differentiation stage. The morphology as well as the pattern of surface marker expression of the X-RAR -positive CFUs defines early precursors, which are nevertheless already committed to myeloid differentiation. In contrast to X-RAR , AML-1/ETO seems to allow HSCs to further differentiate. This is in accordance with recent findings showing that AML-1/ETO only blocks differentiation but does not accelerate cell cycle progression 29, 30 . It seems that AML-1/ETO allows HSCs to reach a stage of differentiation in which the progenitor cells acquire a balance between block of differentiation and concomitant inhibition of proliferation, whereas X-RAR -positive blasts are blocked at an earlier stage associated with an increased proliferation. The contrast between the combined effect of X-RAR on differentiation as well as on cell cycle progression and the single effect of AML-1/ETO on
may explain why patients with AML-M2 in remission can carry the t(8;21) translocation (AML-1/ETO) for years without relapse from their disease 31 , whereas t(15;17) (PML/RAR)-positive APL will relapse within a few months after becoming minimal residual disease-positive 32 .
We recently have shown that in cell line models AATPs are able to activate the Wnt-signaling pathway by up-regulating the expression of -catenin. Moreover blast cells from patients harboring either t (15;17) or t(8;21) express high levels of -catenin 22 . The increased self-renewal of HSCs upon expression ofcatenin is comparable to that observed in HSCs upon over-expression of -catenin as well as upon activation of the Wnt-signaling pathway through its ligands Wnt5a and Wnt3a [19] [20] [21] .
The over-expression of -catenin is unable to completely recapitulate the AATPs-induced phenotype in
HSCs, because -catenin is unable to block differentiation of a bulk Sca1+/lin-population. This is in accordance with recent findings showing that the exposure of HSCs to Wnt3a leads to increased selfrenewal in serum free conditions, whereas differentiation is possible in a conditioned medium 19 .
Nevertheless, activation of the Wnt-signaling through the over-expression of -catenin seems to block differentiation 20 . These differences may be explained by the fact that we used -catenin instead ofcatenin as a mediator of Wnt-signaling.
Serial replating of HSCs over-expressing -catenin selects a very small population of very early HSCs.
Therefore one could hypothesize that the over-expression of -catenin is able to block differentiation only of very early stem cells. Thus there are two levels in which AATP-expressing cells are blocked in their differentiation: one at a very early stem cell level due to the induction of -catenin, and one at a more advanced level of differentiation due to other factors impaired by the AATPS, such as i.e. C/EBP 33 . In fact, CFUs morphologically similar to the -catenin-positive CFUs were frequently detectable also among the AATP expressing CFUs.
The up-regulation of -catenin contributes to the leukemogenesis related to AATPs. This is proven by the fact that the up-regulation of -catenin is indispensable for the increase of self-renewal induced by the AATPs. Hence there seems to be a limiting step during HSCs development which requires activation of the Wnt-signaling pathway through -catenin. This role of -catenin is not restricted to leukemic blasts, Based on the data that purified Wnt3a retains the HSCs at a c-kit+ and Sca1+ HSCs phenotype level, but fails to inhibit differentiation, it has been proposed to employ the activation of Wnt-signaling to expand human HSCs for therapeutic purposes 19, 21 . Such an approach has to be carefully validated. The fact that the over-expression of -catenin leads to a block of differentiation of a very early stem cell strongly suggests a leukemic potential of a constitutively activated Wnt-signaling. In fact mice transplanted with HSCs constitutively over-expressing -catenin exhibits an impaired hematopoiesis with the possible development of AML. The late onset of the leukemia can be explained in two ways: i) only a very low number of cells at a stem cell stage early enough to be blocked in differentiation by -catenin were inoculated into recipients; ii) the need to acquire additional "hits" for full transformation. These data outline the risk of the induction of a leukemic state by a long term activation of Wnt-signaling. which had no effect on -catenin expression (data not shown). C Effect of siRNA-25 on the replating efficiency of Sca1+/lin-HSCs expressing AATPs. As control was used the siRNA-LacZ (III-V -the number of the plating round) D Effect of siRNA-25 on the differentiation block induced by AATPs. As control was used the siRNA-LacZ. As marker of myeloid differentiation were detected GR-1 and Mac-1 and as stem marker were detected Sca1 and c-kit.
Figure 7
Leukemogenic potential of Sca1+/lin-transduced with -catenin and inoculated into sublethally irradiated mice. A-C Analysis of the mouse which developed disease symptomes after 9 months A Westernblot analysis of -catenin expression in the MNC isolated from the BM and the spleen. Equal protein loading was confirmed after stripping of the membrane and staining with an anti--tubulin antibody. B
Morphology of BM and spleen cells stained with May-Grünwald Giemsa. Two magnifications are given (x 400 and x 600, respectively). C Immunological characterization of BM and spleen cells. GR-1and
